Heart to heart: Novo Nordisk teams with ACC to open diabetes discussion

Heart to heart: Novo Nordisk teams with ACC to open diabetes discussion

Source: 
Fierce Pharma
snippet: 

To help bridge the gap, Novo Nordisk is partnering with the American College of Cardiology (ACC) in a two-year, two-pronged initiative. First, the partners will study real-world data to determine patterns and adherence to guidelines. Next, they'll explore how to help Type 2 patients improve their heart health, working through ACC clinicians and healthcare providers, Novo Chief Medical Officer Todd Hobbs said.